Recent evidence suggests that some prostate cancer patients may present PSA levels below 4.0 ng/mL, while PSA levels can be affected by various other factors, such as prostatitis, urinary tract infection, and benign prostate hyperplasia (BPH) [6–8]. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.